ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1887

Facebook Support Groups in Systemic Lupus Erythematosus: Content Analysis

Evelyne Vinet1, William Shihao Lao2, Christian A. Pineau3, Ann E. Clarke4 and Sasha Bernatsky5, 1McGill University Health Center, Montreal, QC, Canada, 2Medicine, McGill University, Montreal, QC, Canada, 3Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 4Clinical Epidemiology, MUHC, Montreal, QC, Canada, 5Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Social support and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Medical Education

Session Type: Abstract Submissions (ACR)

Background/Purpose: Facebook is the most important social network site, with over 600 million registered users worldwide. Many disease-specific groups exist on Facebook, offering a convenient way to exchange information and support, particularly for patients affected with a rare disease such as systemic lupus erythematosus (SLE). However, no one has explored the content of SLE-related groups on Facebook. We aimed to evaluate the purpose of the SLE-related groups on Facebook, and assess the patterns of use and the information shared on the groups dedicated to support.

Methods: We searched Facebook groups using the term “lupus”, from 10/08/2011 to 01/04/2012. We selected groups related to SLE, operating in English or French, and publicly accessible. We extracted information on the purpose of the group and its administrator, as well as on the number and type of user-generated contributions. We analyzed the content of support groups using a previously developed coding scheme.

Results: We found 173 SLE groups on Facebook containing a total of 42 240 members. Half (49%) of the groups were created for support, while 32% were for disease awareness and 14% for fundraising. The largest group included 30 972 members and was intended for awareness. 3469 members were found in support groups, representing 31% of the overall membership (when excluding the largest group), and the median number of members was 11 (interquartile range, IQR, 39). The most frequent support group locations of origin were the United States (46%), Canada (10%), and United Kingdom (10%). In support groups, the total number of user-generated contributions was 1932, including wall posts (54%), comments (32%), discussion posts (10%), and discussion threads (4%), while the median number of user-generated contributions was 5 (IQR 20).

Conclusion: Support groups represent a substantial proportion of Facebook groups dedicated to SLE. Given their convenience, accessibility, and potential audience, Facebook support groups might represent an efficient way to reach patients with SLE and improve their wellbeing. Further research should evaluate the effect of this type of support groups on patients with SLE.


Disclosure:

E. Vinet,
None;

W. S. Lao,
None;

C. A. Pineau,
None;

A. E. Clarke,
None;

S. Bernatsky,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/facebook-support-groups-in-systemic-lupus-erythematosus-content-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology